(Q46045890)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23486531%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

title

Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23486531%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23486531%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Alan F List

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23486531%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Jaroslaw P. Maciejewski

18

object named as

J P Maciejewski

0 references

author name string

S N Khan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23486531%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

A M Jankowska

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23486531%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

A J Dunbar

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23486531%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Y Sugimoto

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23486531%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

N Hosono

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23486531%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Z Hu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23486531%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

V Cheriyath

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23486531%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

S Vatolin

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23486531%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

B Przychodzen

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23486531%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

F J Reu

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23486531%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Y Saunthararajah

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23486531%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

C O'Keefe

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23486531%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

M A Sekeres

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23486531%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

A R Moliterno

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23486531%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

M A McDevitt

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23486531%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

H Makishima

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23486531%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

publication date

14 March 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23486531%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23486531%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23486531%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23486531%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

page(s)

1301-1309

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23486531%20AND%20SRC:MED&resulttype=core&format=json

Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.

25 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.80

Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.80

Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.80

Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.80

Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.80

The polycomb group protein EZH2 is involved in progression of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.80

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.80

The enhancer of zeste homolog 2 gene contributes to cell proliferation and apoptosis resistance in renal cell carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.80

EZH2 Y641 mutations in follicular lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.80

EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.80

The polycomb-group gene Ezh2 is required for early mouse development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.80

Inactivation of polycomb repressive complex 2 components in myeloproliferative and myelodysplastic/myeloproliferative neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.80

FISH and SNP-A karyotyping in myelodysplastic syndromes: improving cytogenetic detection of del(5q), monosomy 7, del(7q), trisomy 8 and del(20q)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.80

Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.80

Direct chromatin PCR (DC-PCR): hypotonic conditions allow differentiation of chromatin states during thermal cycling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.80

pRB family proteins are required for H3K27 trimethylation and Polycomb repression complexes binding to and silencing p16INK4alpha tumor suppressor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.80

Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.80

Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.80

Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.80

Clinical effect of point mutations in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.80

EZH2 mutational status predicts poor survival in myelofibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.80

Updates in cytogenetics and molecular markers in MDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.80

Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.80

Myeloproliferative neoplasms: molecular pathophysiology, essential clinical understanding, and treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.80

Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.80

Prognostic significance of ASXL1 mutations in patients with myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.80

Cloning of a human homolog of the Drosophila enhancer of zeste gene (EZH2) that maps to chromosome 21q22.2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.80

Mammalian homologues of the Polycomb-group gene Enhancer of zeste mediate gene silencing in Drosophila heterochromatin and at S.cerevisiae telomeres

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.80

SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.80

Akt-mediated phosphorylation of EZH2 suppresses methylation of lysine 27 in histone H3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.80

Frequent pathway mutations of splicing machinery in myelodysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.80

Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.80

Role of the polycomb group proteins in hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.80

Polycomb group proteins: multi-faceted regulators of somatic stem cells and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.80

Defining roles for HOX and MEIS1 genes in induction of acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.80

Hoxa9 immortalizes a granulocyte-macrophage colony-stimulating factor-dependent promyelocyte capable of biphenotypic differentiation to neutrophils or macrophages, independent of enforced meis expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.80

A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.80

Molecular profiling of chronic myelomonocytic leukemia reveals diverse mutations in >80% of patients with TET2 and EZH2 being of high prognostic relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.80

Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.80

7 January 2021

Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.80

7 January 2021

Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.80

7 January 2021

ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.80

7 January 2021